Title Credit Type Event datesort descending Cost
The Role of TAVR in Improving Outcomes in Women with Aortic Stenosis: Assessing the Evidence and Clinical Pearls
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
AhR Agonists for Psoriasis: A Novel Mechanism for Treatment of PsO
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Clinical Insights into Psoriasis in Patients of Color: Bringing New Data to Light
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Advances in Managing Eosinophilic Esophagitis: Tips for the Practicing Clinician
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Participation
 Enduring $0.00
Tackling the Disproportionate Burden of Resistant Hypertension in Black Adults
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Ace the Case Challenge Series: The Intersection of MASH and Cardiometabolic Risk
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Pharmaceutical & Commercial Cannabinoid Products Enduring $49.00
Ace the Case Challenge Series: Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
Challenges and Solutions in Lipid-Lowering Therapy in Women: From Gaps to Practice-Changing Advances
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00
MATE ACT Module
    • 8.25 ACCME (MD/DO Only)
    • 8.25 AANP
    • 8.25 ACCME (All Other)
    • 8.25 AAPA Category I CME
 Enduring $299.00
According to the Patient: Alopecia Areata in Adolescence
    • 1.00 AAPA Category I CME
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
New Hope on the Horizon - Advances in the Diagnosis and Treatment of Idiopathic Hypersomnia
    • 1.75 ACPE Pharmacy
    • 1.75 AMA PRA Category 1 Credit™
    • 1.75 ANCC
    • 1.75 Participation
 Enduring $0.00
Exploring Novel Strategies for LDL-C Combination Therapy to Decrease ASCVD Risk: A Paradigm Shift
    • 1.50 CDE
    • 1.50 ACPE Pharmacy
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 ANCC
    • 1.50 Participation
 Enduring $0.00

Pages